These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Acute leukemia following prolonged cytotoxic agent therapy. Casciato DA; Scott JL Medicine (Baltimore); 1979 Jan; 58(1):32-47. PubMed ID: 105227 [TBL] [Abstract][Full Text] [Related]
7. Adrenal steroids in the treatment of malignant hematologic disease. Cline MJ Med Clin North Am; 1973 Sep; 57(5):1203-9. PubMed ID: 4205834 [No Abstract] [Full Text] [Related]
8. Second cancers following antineoplastic therapy. Dorr FA; Coltman CA Curr Probl Cancer; 1985 Feb; 9(2):1-43. PubMed ID: 3888536 [TBL] [Abstract][Full Text] [Related]
9. Fludarabine phosphate in lymphoma: an important new therapeutic agent. McLaughlin P; Robertson LE; Keating MJ Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771 [No Abstract] [Full Text] [Related]
10. [Non-Hodgkin lymphoma in patients with Hodgkin's disease]. Somers R; van Heerde P Ned Tijdschr Geneeskd; 1983 Jan; 127(2):55-9. PubMed ID: 6828172 [No Abstract] [Full Text] [Related]
11. Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects. Brusamolino E; Pagnucco G; Bernasconi C Haematologica; 1986; 71(1):60-83. PubMed ID: 3084360 [No Abstract] [Full Text] [Related]
12. [Results of cytostatic therapy of malignant hemoblastoses]. Stacher A Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311 [No Abstract] [Full Text] [Related]
13. [Therapy of immunoproliferative diseases]. Quattrin N; Ventruto V; Dini E; Montuori R Haematol Lat; 1969; 12(3):743-53. PubMed ID: 4097257 [No Abstract] [Full Text] [Related]
14. [Principles of treatment of hemoblastoses under ambulatory conditions]. Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780 [No Abstract] [Full Text] [Related]
15. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases]. Havemann K; Schmidt M; Malchow H; Sodomann CP Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105 [No Abstract] [Full Text] [Related]
16. [The treatment of hemoblastoses and malignant lymphomas. Neoplasms of the lymphoreticular tissue, plasmacytoma and Waldenström's disease. (II)]. Löffler H; Schultis K Med Welt; 1968 Feb; 6():393-6. PubMed ID: 4977038 [No Abstract] [Full Text] [Related]
17. [Lithium carbonate in prevention of leukopenia/caused by antineoplastic drugs]. Orlando S; Baroni MC; Crotti G; Mineo F; Capra A; Coiro V; Delsignore R G Clin Med; 1981 May; 62(5):351-9. PubMed ID: 6791980 [No Abstract] [Full Text] [Related]
18. Benzene as a leukemogenic and carcinogenic agent. Aksoy M Am J Ind Med; 1985; 8(1):9-20. PubMed ID: 4025342 [TBL] [Abstract][Full Text] [Related]
19. [Daunoblastine in the treatment of leukemias and lymphoreticular neoplasms]. Bile G; De Biasi R Haematologica; 1969; 54(8):523-34. PubMed ID: 4986885 [No Abstract] [Full Text] [Related]